Organized by the Spanish Society of Infectious Diseases & Clinical Microbiology (SEIMC)
Thursday, September 29th (15h00-16h30)
Room B

Organized by:

Multiresistant bacteria infections are a threat to global health, because of their frequency and the current shortage of antimicrobial active, causing high morbidity and mortality. This led the WHO declared a global alert on this issue in 2014.

 The session will: i) to demonstrate the ability of our country to develop new methods of diagnosis and treatment for infections by multidrug-resistant bacteria, through two of the papers, also showing a multidisciplinary approach, since its development participating organic chemists, microbiologists, biologists and physicians; ii) interaction with scientists of international recognition, as evidenced by the third paper.


José Miguel Cisneros Herreros: VicePresident, SEIMC / Director, Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine,  University HOSPITALS VIRGEN MACARENA & VIRGEN DEL ROCÍO of Sevilla (Spain)


  • Laurent Poirel:  Medical and molecular Microbiology Unit, Department of Medicine, Faculty of Science, UNIVERSITY OF FRIBOURG (Switzerland). “Rapid biochemical and culture-based techniques for detecting multidrug resistance in Gram-negative bacteria”
  • José María Marimón Ortiz de Zárate:  Respiratory Infections and Antimicrobial Resistance, Department of Microbiology, Hospital of Donostia, INSTITUTE OF SANITARY RESEARCH BIODONOSTIA (Spain).  “From the hospital to the biotech companies: collaborative development of a new system for characterization of Streptococcus pneumoniae”
  • Jerónimo Pachón:  Infectious Diseases Research Group, Institute of Biomedicine of Seville, UNIVERSITY HOSPITAL VIRGEN DEL ROCIO / CSIC / UNIVERSITY OF SEVILLE (Spain). “Inhibitors of outer membrane protein A for the treatment of severe infections by Gramnegative bacilli”.